Soundzilla
RU

Download "Petauri Evidence" as MP3

19 matches for "Petauri Evidence". Press "Download" to choose format and quality.

  1. Petauri Evidence at ISPOR Annual 2025 - Montreal 0:46

    Petauri Evidence at ISPOR Annual 2025 - Montreal

    Petauri Evidence 0:46 MP3 ~1.1 MB

  2. We are Petauri Evidence 1:05

    We are Petauri Evidence

    Petauri Evidence 1:05 MP3 ~1.5 MB

  3. Navigating US payer evidence needs to optimise market access 57:35

    Navigating US payer evidence needs to optimise market access

    Petauri Evidence 57:35 MP3 ~79.1 MB

  4. What evidence do US payers want to see? 2:01

    What evidence do US payers want to see?

    Petauri Evidence 2:01 MP3 ~2.8 MB

  5. Evidence strategy for Medical Technologies and Diagnostics 53:25

    Evidence strategy for Medical Technologies and Diagnostics

    Petauri Evidence 53:25 MP3 ~73.4 MB

  6. Designing a Global Market Access Strategy Built for MFN 1:00:12

    Designing a Global Market Access Strategy Built for MFN

    Petauri Evidence 1:00:12 MP3 ~82.7 MB

  7. What’s Cost Got to Do With It?  - Reviewing  Key Issues Related to Costs in HTA 9:23

    What’s Cost Got to Do With It? - Reviewing Key Issues Related to Costs in HTA

    Petauri Evidence 9:23 MP3 ~12.9 MB

  8. The dynamic nature of network meta-analysis: how data updates could influence HTA 5:30

    The dynamic nature of network meta-analysis: how data updates could influence HTA

    Petauri Evidence 5:30 MP3 ~7.6 MB

  9. Communicating value to US Payers: Insights for Pharma and Medtech 59:03

    Communicating value to US Payers: Insights for Pharma and Medtech

    Petauri Evidence 59:03 MP3 ~81.1 MB

  10. Introduction and Software Implementation of Non-Proportional Hazards in Network Meta-Analysis 1:00:10

    Introduction and Software Implementation of Non-Proportional Hazards in Network Meta-Analysis

    Petauri Evidence 1:00:10 MP3 ~82.6 MB

  11. AI in systematic review: accuracy, efficiency and performance 6:38

    AI in systematic review: accuracy, efficiency and performance

    Petauri Evidence 6:38 MP3 ~9.1 MB

  12. First to Market: Unlocking Switzerland’s Pharma Potential 44:32

    First to Market: Unlocking Switzerland’s Pharma Potential

    Petauri Evidence 44:32 MP3 ~61.2 MB

  13. NICE move from MTEP to  HealthTech program: Evolving evidence expectations for medtech HTA 4:43

    NICE move from MTEP to HealthTech program: Evolving evidence expectations for medtech HTA

    Petauri Evidence 4:43 MP3 ~6.5 MB

  14. World EPA 2025 0:22

    World EPA 2025

    Petauri Evidence 0:22 MP3 ~0.5 MB

  15. Which types of evidence are valued in the US market? 2:01

    Which types of evidence are valued in the US market?

    Petauri Evidence 2:01 MP3 ~2.8 MB

  16. What evidence do you need to launch a new product in the NHS? 4:09

    What evidence do you need to launch a new product in the NHS?

    Petauri Evidence 4:09 MP3 ~5.7 MB

  17. Webinar: Global Pricing and Market Access – Strategies for Success in an Evolving Landscape 52:42

    Webinar: Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

    Petauri Evidence 52:42 MP3 ~72.4 MB

  18. AMCP Dossier Format v5.0: US Payer Preferences and Utilization to Support Formulary Decision Making 6:06

    AMCP Dossier Format v5.0: US Payer Preferences and Utilization to Support Formulary Decision Making

    Petauri Evidence 6:06 MP3 ~8.4 MB

  19. Highlights from ISPOR Europe 2024 1:04

    Highlights from ISPOR Europe 2024

    Petauri Evidence 1:04 MP3 ~1.5 MB